Published in Br Med J on August 14, 1976
Deception among smokers. Br Med J (1978) 3.90
Clinical use of nicotine chewing-gum. Br Med J (1980) 2.79
Placebo controlled trial of nicotine chewing gum in general practice. Br Med J (Clin Res Ed) (1984) 2.13
Nicotine chewing gum as a substitute for smoking. Br Med J (1977) 1.36
Rational development of addiction pharmacotherapies: successes, failures, and prospects. Cold Spring Harb Perspect Med (2012) 0.89
Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials. Nicotine Tob Res (2011) 0.88
Does nicotine chewing gum work? Br Med J (Clin Res Ed) (1985) 0.87
Giving up smoking. Thorax (1984) 0.85
Chewing nicotine gum for 3 months: what happens to plasma nicotine levels? Can Med Assoc J (1984) 0.78
The effects of supplementary nicotine in regular cigarette smokers. Postgrad Med J (1977) 0.78
The Belfast smoking withdrawal centre: a preliminary report. Ulster Med J (1978) 0.75
The effect of anosmia on smoking habits. Postgrad Med J (1981) 0.75
Absorption by non-smokers of carbon monoxide from room air polluted by tobacco smoke. Lancet (1973) 5.52
Comparison of effect on tobacco consumption and carbon monoxide absorption of changing to high and low nicotine cigarettes. Br Med J (1973) 2.65
Plasma nicotine levels after cigarette smoking and chewing nicotine gum. Br Med J (1976) 2.31
An evaluation of current methods of modifying smoking behavior. J Clin Psychol (1974) 2.08
A substitute for tobacco smoking. Psychopharmacologia (1973) 1.91
Nicotine-containing chewing gum as an anti-smoking aid. Psychopharmacologia (1973) 1.62
Nicotine regulation and cigarette smoking. Clin Pharmacol Ther (1975) 1.57
Temporal contiguity in electric aversion therapy for cigarette smoking. Behav Res Ther (1976) 1.27
Effect of general practitioners' advice against smoking. Br Med J (1979) 24.07
THE NATURE OF THE PERIPHERAL RESISTANCE IN ARTERIAL HYPERTENSION WITH SPECIAL REFERENCE TO THE VASOMOTOR SYSTEM. J Clin Invest (1936) 18.94
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2000) 16.83
Intercapillary Lesions in the Glomeruli of the Kidney. Am J Pathol (1936) 12.50
Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med (1999) 11.27
Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health (1987) 8.59
A plethysmographic method for measuring systolic blood pressure in the intact rat. J Physiol (1938) 7.20
Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet (2001) 6.92
Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol (1991) 6.19
P-element-mediated enhancer detection: a versatile method to study development in Drosophila. Genes Dev (1989) 5.76
Absorption by non-smokers of carbon monoxide from room air polluted by tobacco smoke. Lancet (1973) 5.52
Changes in cigarette price and consumption by men in Britain, 1946-71: a preliminary analysis. Br J Prev Soc Med (1973) 5.35
A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol (1990) 4.84
Expired air carbon monoxide: a simple breath test of tobacco smoke intake. Br Med J (1980) 4.82
Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. Br Med J (1980) 4.76
Benign and Malignant Hypertension and Nephrosclerosis: A Clinical and Pathological Study. Am J Pathol (1936) 4.43
Genetic evidence for the spread of agriculture in Europe by demic diffusion. Nature (1991) 4.34
Cigarette dependence: II. Doctor's role in management. Br Med J (1971) 3.99
Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health (1984) 3.95
A cytogenetic study of 1000 spontaneous abortions. Ann Hum Genet (1980) 3.82
Improved gas chromatographic method and micro-extraction technique for the measurement of nicotine in biological fluids. J Pharm Pharmacol (1979) 3.72
Realistic goals for smoking and health. A case for safer smoking. Lancet (1974) 3.68
Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature (1984) 3.64
Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking. Br Med J (Clin Res Ed) (1983) 3.64
Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A (1997) 3.61
Low-tar medium-nicotine cigarettes: a new approach to safer smoking. Br Med J (1976) 3.55
Inflammatory Lesions in the Glomeruli in Pyelonephritis in Relation to Hypertension and Renal Insufficiency. Am J Pathol (1936) 3.52
New world views: preparing physicians in training for global health work. Fam Med (2000) 3.23
A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila. Genes Dev (1996) 3.21
Smoking in Britain: strategy for future emancipation. Br J Addict Alcohol Other Drugs (1971) 3.06
Cardiovascular effects of implanted acrylic bone cement. Br Med J (1971) 3.05
Randomised controlled trial of nicotine chewing-gum. Br Med J (Clin Res Ed) (1982) 2.92
Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ (1993) 2.91
Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene. Cell (1988) 2.91
Smoking during pregnancy and its effects on the fetus. J Obstet Gynaecol Br Commonw (1972) 2.91
Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90
Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev (1999) 2.87
Passive smoking, salivary cotinine concentrations, and middle ear effusion in 7 year old children. BMJ (1989) 2.81
Plasma nicotine levels after smoking cigarettes with high, medium, and low nicotine yields. Br Med J (1975) 2.80
Structure of the CAP-DNA complex at 2.5 angstroms resolution: a complete picture of the protein-DNA interface. J Mol Biol (1996) 2.80
Clinical use of nicotine chewing-gum. Br Med J (1980) 2.79
Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction (1995) 2.71
Cigarette smoking: natural history of a dependence disorder. Br J Med Psychol (1971) 2.71
Comparison of effect on tobacco consumption and carbon monoxide absorption of changing to high and low nicotine cigarettes. Br Med J (1973) 2.65
RNA secondary structure prediction based on free energy and phylogenetic analysis. J Mol Biol (1999) 2.65
Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. Am J Public Health (1988) 2.63
Passive exposure to tobacco smoke: saliva cotinine concentrations in a representative population sample of non-smoking schoolchildren. Br Med J (Clin Res Ed) (1985) 2.51
Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. Eur Respir J (1999) 2.44
Assay of nicotine in biological materials: sources of contamination and their elimination. J Pharm Pharmacol (1980) 2.43
Inhalation of tobacco smoke by pipe and cigar smokers. Lancet (1973) 2.39
Cigarette smoking: a dependence on high-nicotine boli. Drug Metab Rev (1978) 2.36
Saliva cotinine as an indicator of cigarette smoking in adolescents. Br J Addict (1987) 2.33
Blood carboxyhaemoglobin, plasma thiocyanate, and cigarette consumption: implications for epidemiological studies in smokers. Br Med J (Clin Res Ed) (1982) 2.32
Plasma nicotine levels after cigarette smoking and chewing nicotine gum. Br Med J (1976) 2.31
Carboxyhaemoglobin and plasma thiocyanate: complementary indicators of smoking behaviour? Thorax (1982) 2.30
Rapid gas-liquid chromatographic determination of cotinine in biological fluids. Analyst (1980) 2.29
Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys. BMJ (2000) 2.28
A computer-derived protocol to aid in the diagnosis of emergency room patients with acute chest pain. N Engl J Med (1982) 2.28
Mobile coronary care and community mortality from myocardial infarction. Lancet (1985) 2.27
What determines levels of passive smoking in children with asthma? Thorax (1997) 2.20
Determinants of passive smoking in children in Edinburgh, Scotland. Am J Public Health (1992) 2.17
Stimulation and suppression of PCR-mediated recombination. Nucleic Acids Res (1998) 2.17
Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey. J Natl Cancer Inst (2001) 2.16
Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness. Lancet (1999) 2.15
Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther (1995) 2.11
A microtest for the quantitation of rabies virus neutralizing antibodies. J Biol Stand (1979) 2.10
The treatment and prevention of obesity: a systematic review of the literature. Int J Obes Relat Metab Disord (1997) 2.10
Adjustment of smokers to dilution of tobacco smoke by ventilated cigarette holders. Clin Pharmacol Ther (1978) 2.09
Improving the detection rate of early gastric cancer requires more than open access gastroscopy: a five year study. Gut (1997) 2.09
On the scale of global demographic convergence, 1950-2000. Popul Dev Rev (2001) 2.07
A new age for snuff? Lancet (1980) 2.06
Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.06
Exposure to passive smoking among bar staff. Br J Addict (1992) 2.06
Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem (1994) 2.04
TRAUMATIC DIAPHRAGMATIC HERNIA. Ann Surg (1930) 2.02